BSE filing, NSE: CREST. Summary written from the filing by ALFA Finder's alert engine.
Crest Ventures Ltd: key numbers
- Share price
- ₹361.00
- Market cap
- ₹1,027 Cr
- Revenue (annual)
- ₹159.1 Cr
- Net profit (annual)
- ₹46.83 Cr
- P/E (TTM)
- 29.8×Sector 19.8×
- Promoter holding
- 69.84%+0.00% QoQ
- FII holding
- 1.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Crest Ventures Ltd
All →Crest Ventures Other Announcement
Crest Ventures Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Crest Ventures Debt & Borrowing
Crest Ventures reported its half-yearly outstanding NCD statement for September 30, 2026. ₹100 Crore in 12% NCDs remain outstanding, maturing June 2027.
Crest Ventures Debt & Borrowing: ₹3.02 Cr
Crest Ventures Ltd paid ₹3.02 Crore quarterly interest on its 12% NCDs (12CVL27). The payment was made on the due date of 23 September 2026.
- Value
- ₹3.02 Cr
Crest Ventures Annual General Meeting
Crest Ventures Limited filed the minutes of its 44th Annual General Meeting held on August 22, 2026. The meeting covered adoption of financials and dividend approval.
Crest Ventures Annual General Meeting
Crest Ventures held its 44th Annual General Meeting on August 22, 2026, to transact business items and provide management updates on company performance.
Crest Ventures Merger & Restructuring
Crest Ventures incorporated two new step-down wholly owned subsidiaries, EZY Living Nest and EZY Living Spaces. Both entities will undertake real estate development activities in Maharashtra.
Other board meeting date announcements
All →Esha Media Research Board Meeting Date
Esha Media Research will hold a board meeting on November 4, 2026 to consider unaudited results. Trading window stays closed until 48 hours after results declaration.
Trident Texofab Board Meeting Date
Trident Texofab schedules a board meeting on 5 November 2026 to consider unaudited quarterly results. No financial figures are disclosed yet.
Aspira Pathlab & Diagnostics Board Meeting Date
Aspira Pathlab & Diagnostics will hold a board meeting on November 6, 2026 to consider unaudited standalone results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after the results.
Advance Agrolife Board Meeting Date
Advance Agrolife's board meets on 4 November 2026 to approve unaudited standalone September quarter results. Trading window stays closed until 48 hours post-declaration.
Axiom Gas Engineering Board Meeting Date
Axiom Gas Engineering will meet on 7 November 2026 to consider unaudited half-yearly results. The trading window stays closed until the meeting concludes.
RSC International Board Meeting Date
RSC International has called a board meeting on November 5, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after the results are declared.